Literature DB >> 25518895

Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey.

G Tocci1, A F Cicero2, M Salvetti3, P Francia4, A Ferrucci4, C Borghi2, M Volpe1.   

Abstract

The aim of this study was to evaluate attitudes and preferences for the clinical management of hypertensive patients with cardiac organ disease, including left ventricular hypertrophy (LVH) and coronary artery disease (CAD), in Italy. A predefined 15-item questionnaire was anonymously administered to a large community sample of general practitioners (GPs) and specialised physicians between November 2012 and June 2013. Estimated prevalence of hypertension-related clinical conditions was stratified into four groups (10-20%, 20-40%, 40-50%, >50%); preferences were reported as percentage among valid answers to the survey questionnaire. A total of 1319 physicians (672 males, age 55.0 ± 7.1 years, age of medical activity 27.1 ± 7.6 years), among whom 1264 GPs and 55 specialised physicians, was included. LVH was reported to be the most frequent marker of organ damage by the majority of physicians (73.5%). LV diastolic dysfunction was reported to be relatively frequent (>40%) by more than half of the specialised physicians (58.2%) and less frequent (10-20%) by GPs (49.8%); LV systolic dysfunction, atrial fibrillation and CAD were considered to be less frequent (10-20%) by the majority of physicians (61.3, 71.6 and 53.3%, respectively). Echocardiography was the preferred diagnostic tool used to estimate LVH (76.6%). Tight blood pressure control (130/80 mm Hg) was considered to be the most appropriate by the majority of physicians, both in hypertensive patients with LVH and in those with CAD. With the well-known limitations of a cross-sectional survey, this study provides information on attitudes and preferences for the clinical management of outpatients with hypertension and high CV risk profile in general practice in Italy.

Entities:  

Mesh:

Year:  2014        PMID: 25518895     DOI: 10.1038/jhh.2014.115

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  29 in total

1.  Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

Authors:  R Cifkova; S Erdine; R Fagard; C Farsang; A M Heagerty; W Kiowski; S Kjeldsen; T Lüscher; J M Mallion; G Mancia; N Poulter; K H Rahn; J L Rodicio; L M Ruilope; P van Zwieten; B Waeber; B Williams; A Zanchetti
Journal:  J Hypertens       Date:  2003-10       Impact factor: 4.844

Review 2.  Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers.

Authors:  Massimo Volpe; Allegra Battistoni; Giuliano Tocci; Enrico Agabiti Rosei; Alberico L Catapano; Rosanna Coppo; Stefano del Prato; Sandro Gentile; Elmo Mannarino; Salvatore Novo; Domenico Prisco; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

3.  Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study.

Authors:  M Lorenza Muiesan; Massimo Salvetti; Anna Paini; Cristina Monteduro; Claudia Agabiti Rosei; Carlo Aggiusti; Eugenia Belotti; Fabio Bertacchini; Gloria Galbassini; Deborah Stassaldi; Maurizio Castellano; Enrico Agabiti Rosei
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

4.  Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice.

Authors:  Giovanni Corrao; Federica Nicotra; Andrea Parodi; Antonella Zambon; Franca Heiman; Luca Merlino; Ida Fortino; Giancarlo Cesana; Giuseppe Mancia
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

5.  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors:  Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

6.  Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Bjorn Dahlof
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

Review 7.  Cardiovascular care facts: a report from the national cardiovascular data registry: 2011.

Authors:  Frederick A Masoudi; Angelo Ponirakis; Robert W Yeh; Thomas M Maddox; Jim Beachy; Paul N Casale; Jeptha P Curtis; James De Lemos; Gregg Fonarow; Paul Heidenreich; Christina Koutras; Mark Kremers; John Messenger; Issam Moussa; William J Oetgen; Matthew T Roe; Kenneth Rosenfield; Thomas P Shields; John A Spertus; Jessica Wei; Christopher White; Christopher H Young; John S Rumsfeld
Journal:  J Am Coll Cardiol       Date:  2013-09-18       Impact factor: 24.094

8.  Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Authors:  Giampiero Mazzaglia; Ettore Ambrosioni; Marianna Alacqua; Alessandro Filippi; Emiliano Sessa; Vincenzo Immordino; Claudio Borghi; Ovidio Brignoli; Achille P Caputi; Claudio Cricelli; Lorenzo G Mantovani
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

9.  Survival in treated hypertension: follow up study after two decades.

Authors:  O K Andersson; T Almgren; B Persson; O Samuelsson; T Hedner; L Wilhelmsen
Journal:  BMJ       Date:  1998-07-18

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  4 in total

1.  Metabolic approaches to antihypertensive treatment in diabetic patients.

Authors:  Arrigo F Cicero; Giuliano Tocci
Journal:  Hypertens Res       Date:  2015-10-01       Impact factor: 3.872

2.  Cardiovascular prevention: the role of second generation of nutraceuticals.

Authors:  Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-21

3.  Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire.

Authors:  Giuliano Tocci; Arrigo F Cicero; Massimo Salvetti; Jasmine Passerini; Maria Beatrice Musumeci; Andrea Ferrucci; Claudio Borghi; Massimo Volpe
Journal:  Intern Emerg Med       Date:  2015-05-19       Impact factor: 3.397

4.  Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey.

Authors:  Giuliano Tocci; Arrigo F Cicero; Massimo Salvetti; Maria Beatrice Musumeci; Andrea Ferrucci; Claudio Borghi; Massimo Volpe
Journal:  Clin Hypertens       Date:  2017-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.